Introduction

Molecular Mechanisms of Hormonal Carcinogenesis
  • J. Carl Barrett
Conference paper

Abstract

Hormones play an important role in a number of human cancers. For example, estrogens influence the incidence of mammary, endometrial, and ovarian cancers in women (1). Estrogens are also carcinogenic in animals. The natural estrogen 17β-estradiol increases the incidences of mammary, pituitary, uterine, cervical, vaginal, and lymphoid tumors, and interstitial-cell tumors of the testes in mice; it also increases the incidences of mammary and pituitary tumors in rats and renal tumors in hamsters (2). Similarly, the synthetic estrogen diethylstilbestrol increases the incidences of mammary tumors, lymphoid tumors, interstitial-cell tumors of the testes, cervical tumors, and vaginal tumors in mice; pituitary, mammary, bladder tumors in rats; and renal tumors in hamsters (2).

Keywords

Estrogen Adenocarcinoma Recombination Progesterone Estradiol 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Preston-Martin S, Pike MC, Ross RK, Jones PA, and Henderson BE. Increased cell division as cause of human cancer. Cancer Res. 50: 7415–7421, 1990.Google Scholar
  2. 2.
    International Agency for Research on Cancer, Evaluation of carcinogenic risk of chemicals to humans, sex hormones (11). Vol. 21, IARC, Lyon, 1979.Google Scholar
  3. 3.
    Barrett FC and Huff J. Cellular and molecular mechanisms of chemically induced carcinogenesis. Renal Failure. In press.Google Scholar
  4. 4.
    Kaldor JM and Day NE. Interpretation of epidemiological studies on the context of the multistage model of carcinogenesis. In Barrett JC (ed): Mechanisms of environmental carcinogenesis, Vol. II, CRC Press: Boca Raton, Florida, pp. 21–57, 1987.Google Scholar
  5. 5.
    Forsberg JG. Developmental mechanism of estrogen-induced irreversible changes in the mouse cervicovaginal epithelium. Nat1 Cancer Inst Monogr 51: 41–56, 1979.Google Scholar
  6. 6.
    McLachlan JA, Newbold RR and Bullock RC. Long-term effects on the female mouse genital tract associated with prenatal exposure to diethylstilbestrol. Cancer Res 40: 3988–3999, 1980.PubMedGoogle Scholar
  7. 7.
    Newbold RR, Bullock BC and McLachlan JA. Uterine adenocarcinoma in mice following developmental treatment with estrogens: a model for hormonal carcinogenesis. Cancer Res 50: 7677–7681, 1990.PubMedGoogle Scholar
  8. 8.
    Li JJ, Li SA, Oberley T. Estrogen carcinogenicity: hormonal morphologic and chemical interactions. In Politzer P. & Martin Jr J.F. (eds): Chemical carcinogens. Activation mechanism, structural and electronic factors, and reactivity, New York: Elsevier, 312–321, 1988.Google Scholar
  9. 9.
    Liehr JG. 2-Fluoroestradiol: separation of estrogenicity from carcinogenicity. Mol Pharmacol 23: 278–281, 1983.PubMedGoogle Scholar
  10. 10.
    Barrett JC, Wong A and McLachlan JA. Diethylstilbestrol induces neoplastic transformation without measurable gene mutation in two loci. Science 212: 1402–1404, 1981.PubMedCrossRefGoogle Scholar
  11. 11.
    McLachlan JA, Wong A, Degen GH and Barrett JC. Morphological and neoplastic transformation of Syrian hamster embryo cells by diethylstilbestrol and its analogs. Cancer Res. 42: 3040–3045, 1982.PubMedGoogle Scholar
  12. 12.
    Tsutsui T, Maizume H, McLachlan JA, and Barrett JC. Aneuploidy induction and cell transformation by diethylstilbestrol: a possible chromosome mechanism in carcinogenesis. Cancer Res 3814–3821, 1983.Google Scholar
  13. 13.
    Tsutsui T, Degen GH, Schiffmann D, Wong A, Maizumi H, McLachlan JA, and Barrett JC. Dependence of exogenous metabolic activation for induction of unscheduled DNA synthesis in Syrian hamster embryo cells by diethlstilbestrol and related compounds. Cancer Res 44: 184–189, 1984.PubMedGoogle Scholar
  14. 14.
    Barrett JC. Relationship between mutagenesis and carcinogenesis. In Barrett JC (ed): Mechanisms of environmental carcinogenesis, Vol. I. CRC Press: Boca Raton, Florida, pp. 129–142, 1987.Google Scholar
  15. 15.
    Barrett JC, Oshimura M, Tanaka N, and Tsutsui T. Genetic and epigenetic mechanisms of presumed nongenotoxic carcinogens. In Butterworth B. & Slaga TJ (eds): Nongenotoxic mechanisms in carcinogenesis, New York: Cold Spring Harbor Laboratory, pp. 311–324, 1987.Google Scholar
  16. 16.
    Boyd JC and Barrett JC. Genetic and cellular basis of multistep carcinogenesis. Pharmacol Ther 46: 469–486, 1990.PubMedCrossRefGoogle Scholar
  17. 17.
    Callahan R and Campbell G. Mutations in human breast cancer: An overview. J Natl Cancer Inst 81: 1780–1786, 1989.PubMedCrossRefGoogle Scholar
  18. 18.
    Dickson RB and Slamon. New insights into breast cancer: The molecular biochemical and cellular biology of breast cancer. Cancer Res 50: 4446–4447, 1990.PubMedGoogle Scholar
  19. 19.
    Mars WM and Saunders GF. Chromosomal abnormalities in human breast cancer. Cancer Metastasis Rev 9: 35–43, 1990.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag New York, Inc. 1992

Authors and Affiliations

  • J. Carl Barrett

There are no affiliations available

Personalised recommendations